相关实验视频
Updated: Jun 10, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.5K
灾难性抗脂综合征:对当前证据和未来管理实践的审查
Ayoyimika O Okunlola1, Temitope O Ajao2, Mwila Sabi3
1Internal Medicine, United Lincolnshire Hospitals NHS trust, Lincolnshire, GBR.
Cureus
|October 21, 2024
概括
灾难性抗脂综合征 (CAPS) 是一种严重的自身免疫性疾病,由于血液凝块而导致器官衰竭. 早期诊断和联合治疗,如抗凝血药和免疫抑制剂,可以提高生存率.
科学领域:
- 自免疫性疾病 自免疫性疾病
- 血液学 血液学 血液学
- 类风湿病学 类风湿病学
背景情况:
- 抗脂综合征 (APS) 是一种自身免疫性疾病,与血栓和怀孕问题有关.
- 灾难性APS (CAPS) 是一种危及生命的变种,导致多器官衰竭.
- 病原发生涉及抗脂抗体,触发内皮激活和前血栓状态.
研究的目的:
- 审查灾难性抗脂综合征 (CAPS) 的病原和流行病学.
- 检查CAPS目前的管理策略.
- 讨论CAPS管理中的挑战,争议和未来的研究方向.
主要方法:
- 审查现有的文献和CAPS注册表数据.
- 临床表现的分析,诊断标准,以及他的病理学.
- 评估当前和新兴的治疗方式.
主要成果:
- CAPS主要影响年轻患者,经常患有SLE,并可能导致广泛的微血栓形成.
- 脏,肺,中枢神经系统和心脏是常见的受影响器官.
- 最近在治疗方面取得的进展,包括早期的葡萄糖皮质激素和组合疗法,改善了生存率.
结论:
- 早期诊断和积极的治疗,结合抗凝药,免疫抑制 (皮质类固醇,IVIG,rituximab) 和血交换,对于改善CAPS结果至关重要.
- 维护抗凝剂对于预防复发至关重要.
- 需要进一步的研究来应对挑战并优化管理策略.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
2
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
2
Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
478
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
478
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
1
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
1
Atherosclerosis III: Management
1
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
1

